Boxer Capital, LLC Pmv Pharmaceuticals, Inc. Transaction History

Boxer Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$11.4 - $17.18 $3.82 Million - $5.75 Million	-334,841 Reduced 9.57%	3,163,795 $37.6 Million
Q1 2022 May 16, 2022	BUY	$14.86 - $23.55 $9.81 Million - $15.6 Million	660,400 Added 23.27%	3,498,636 $72.8 Million
Q4 2021 Feb 14, 2022	BUY	$19.99 - $30.24 $11.4 Million - $17.2 Million	570,000 Added 25.13%	2,838,236 $65.6 Million
Q3 2020 Nov 16, 2020	BUY	$35.5 - $38.0 $80.5 Million - $86.2 Million	2,268,236 New	2,268,236 $80.5 Million

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Boxer Capital, LLC with notifications on news.